Latest News

Warner Bros. Discovery fell short of Wall Street expectations in the second quarter, as Supergirl and the lack of the NBA dragged total revenue down 11% to $8.7 billion. Analysts had projected $9.2 bi

SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Wise

Gold is hovering around seven-week highs and enters its fourth consecutive winning session. A weaker ADP report reduces the chances of a Fed rate hike in September, which would provide some relief for

SpaceX's (NASDAQ:SPCX) share unlock timeline has two important milestones this month, with the free float set to jump to 11.8% today, August 6, and to 15.2% on August 20.

Inspired Entertainment, Inc. (INSE) Q2 2026 Earnings Call Transcript

ZUG, Switzerland, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet nee

Q2 2026 TransUnion Credit Industry Insights Report shows balance growth, broader access and measured monthly payment pressure Q2 2026 TransUnion Credit Industry Insights Report shows balance growth, b

SAN DIEGO, Aug. 6, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers Primoris Services Corporation (NYSE: PRIM) common stock between August

Diageo PLC (LSE:DGE) shares jumped 6.3% to 1,744.9p after the booze maker reported higher underlying profit despite lower sales, with chief executive Dave Lewis setting out new strategic priorities fo

Health insurer Oscar Health swung to a $361 million second quarter profit while eclipsing $1 billion in net income for the first six months of the year as health plan membership rose and medical costs

Sanofi is rated a Buy, with 33.5% upside to €99.5 fair value (or $57 for SNY ADRs), resulting from averaging optimistic with pessimistic scenarios. Dupixent remains Sanofi's key growth driver, with a

Second quarter sales grew 5.8% to $917 million, driven by 4.3% organic sales growth and 1.5% favorable foreign exchange, with organic growth in both business segments Second quarter GAAP EPS of $0.70

PepsiCo is underperforming the consumer staples sector, hindered by weak North American volumes and slower growth versus Coca-Cola. I rate PEP a Hold, citing fair valuation, a 4.3% dividend yield, but

Mitsui & Co., Ltd. (MITSY) Q1 2027 Earnings Call Prepared Remarks Transcript

Cytek Biosciences, Inc. (CTKB) Q2 2026 Earnings Call Transcript

Assay results from multiple gold-rich drill intercepts from 2026 drilling, have confirmed expansion of the Bonanza and Golden Gate Zones that remain open (see Figure 1): An accompanying infographic is

Hadrian raised a fresh round of funding at a nearly $8 billion valuation. Defense tech startups are benefiting from President Donald Trump's plan to upgrade the U.S. military.

Array Technologies, Inc. (ARRY) Q2 2026 Earnings Call Transcript

Reported talks of a tie-up between two industry giants could deliver instant U.S. scale for AstraZeneca through Bristol Myers Squibb's U.S.-centric business, but at the cost of slower growth and integ

Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares rose 10% to 1,721p after first-half results came in ahead of expectations on profits, with both Peel Hunt and Stifel keeping buy ratings. The scal